BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for ... MarketWatch (press release) In addition, HCV infection is the leading cause of liver transplantation and is a risk factor for liver cancer. The global Hepatitis market was estimated at $6.5 billion in 2010 and is forecasted to grow to $11.5 billion in 2016. |
